SFL participates in the 50th EMWA conference

The SFL team is at MPP2020

SFL’s CEO to present at lunch webinar on MDR and combined products

SFL to present on regulations in digital health at expert event

SFL marketing authorization application for the orphan medicinal product “Obiltoxaximab SFL” receives CHMP positive option